- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04444232
Cancer Communication Within Hispanic Social Networks
June 19, 2020 updated by: Fred Hutchinson Cancer Center
Cancer Communication Within Social Networks
This trial examines cancer communication within Hispanic social networks.
Hispanics have the lowest colorectal cancer screening rate of any major ethnic group and health interventions are crucially needed among Hispanics.
Patient decision aids are health communication interventions designed to provide patients with targeted health information and have shown to improve colorectal cancer screening rates among Hispanics.
The goal of this study is to investigate, in a sample of Hispanics, how a colorectal cancer decision aid aimed at increasing individuals' colorectal cancer screening behavior has effects on their alters' intention to get screened for colorectal cancer.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
OUTLINE:
Participants view an educational video on cancer and cancer screening options over 12 minutes. Participants also complete a phone survey over 10-15 minutes before attending the video session and 2 months after the video session.
Study Type
Interventional
Enrollment (Actual)
57
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98109
- Fred Hutch/University of Washington Cancer Consortium
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Self-identify as "Hispanic" or "Latino"
- Have no family history of CRC
- Have no personal history of pre-cancerous (adenomatous) colonic polyps
- Have not had either an annual fecal occult blood test (FOBT) within the past year or colonoscopy within the last 10 years (defined as up-to-date with CRC screening by current United States [U.S.] Preventive Services Task Force recommendations)
- Have at least two family members, friends, or co-workers who are ages 50-75
- Alters will be eligible if they are ages 50-75
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Health services research (educational video, survey)
Participants view an educational video on cancer and cancer screening options over 12 minutes.
Participants also complete a phone survey over 10-15 minutes before attending the video session and 2 months after the video session.
|
Complete survey
View an educational video
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' communication with their families, friends, and co-workers about colorectal cancer (CRC) screening
Time Frame: Up to 6 months
|
Will be assessed using a single dichotomized question with two response options ('yes' or 'no').
CRC communication constitutes in-person conversation, email, phone, or post on social media (e.g., blog, Twitter, Facebook).
Will also assess the characteristics of the alters by asking the patients two questions on social-tie dimensions: 1) contact frequency (never, rarely, sometimes, often, or very often) and 2) personal relationship (acquaintance , close friend , co-worker, relatives, or spouse).
|
Up to 6 months
|
|
Alters' intent to become screened for CRC in the next six months
Time Frame: Up to 6 months
|
Intent will be assessed using a single categorical item with three response options (definitely planning to be screened, considering being screened, not considering being screened).
|
Up to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 9, 2014
Primary Completion (ACTUAL)
February 10, 2015
Study Completion (ACTUAL)
March 9, 2015
Study Registration Dates
First Submitted
June 19, 2020
First Submitted That Met QC Criteria
June 19, 2020
First Posted (ACTUAL)
June 23, 2020
Study Record Updates
Last Update Posted (ACTUAL)
June 23, 2020
Last Update Submitted That Met QC Criteria
June 19, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RG1001018
- P30CA015704 (U.S. NIH Grant/Contract)
- NCI-2020-04236 (REGISTRY: CTRP (Clinical Trial Reporting Program))
- 8182 (OTHER: Fred Hutch/University of Washington Cancer Consortium)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.